Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1704095

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1704095

Degenerative Disc Disease Treatment Global Market Report 2025

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Degenerative disc disease treatment encompasses various medical approaches designed to alleviate symptoms and enhance functionality in individuals with degenerative disc disease, a condition where the spinal discs lose their cushioning ability over time. Treatments may include physical therapy, pain management with medications, lifestyle changes, and, in some cases, surgical procedures like discectomy or spinal fusion to relieve nerve pressure and stabilize the spine.

The primary types of treatment for degenerative disc disease are conventional drugs and novel therapies. Conventional drugs involve standard medications used to manage symptoms, such as pain relievers and anti-inflammatory drugs. These medications can be administered orally or via injection and are utilized in various settings, including hospitals, ambulatory surgical centers, and orthopedic centers.

The degenerative disc disease treatment market research report is one of a series of new reports from The Business Research Company that provides degenerative disc disease treatment market statistics, including degenerative disc disease treatment industry global market size, regional shares, competitors with a degenerative disc disease treatment market share, detailed degenerative disc disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the degenerative disc disease treatment industry. This degenerative disc disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The degenerative disc disease treatment market size has grown strongly in recent years. It will grow from $27.07 billion in 2024 to $29.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to an aging population, a sedentary lifestyle, advances in medical technology, increased awareness, rising obesity rates, growing sports injuries, and healthcare access expansion.

The degenerative disc disease treatment market size is expected to see strong growth in the next few years. It will grow to $37.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to rising healthcare expenditure, growing demand for minimally invasive procedures, enhanced patient education, expanding clinical research, and rising global incidence of spine disorders. Major trends in the forecast period include integration of AI and machine learning, the development of regenerative medicine, advancements in minimally invasive surgery, wearable technology, 3D printing for custom implants, telemedicine, and remote consultations, and a focus on personalized medicine.

The increasing incidence of sports injuries is expected to drive the growth of the degenerative disc disease treatment market in the coming years. Sports injuries refer to physical damage or trauma sustained by athletes or individuals involved in physical activities, often caused by sudden impacts, overuse, or improper techniques. The rise in sports injuries is often linked to factors such as higher participation rates, more rigorous training routines, and a stronger focus on competitive performance. Degenerative disc disease treatment is utilized to manage chronic spinal pain and restore function when disc degeneration affects athletes' performance and mobility. For example, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary company, reported that injuries in October 2022 led to players being sidelined for an average of 11.35 days before tournaments, with this number increasing to 19.41 days by January 2023. Therefore, the growing number of sports injuries is fueling the expansion of the degenerative disc disease treatment market.

Leading companies in the degenerative disc disease treatment market are focusing on developing innovative therapies, such as injectable disc cell therapy (IDCT), to enhance patient outcomes by increasing disc volume, relieving low back pain, and reducing reliance on pain medications. Injectable disc cell therapy (IDCT) is a regenerative treatment designed for symptomatic lumbar degenerative disc disease. For instance, in February 2023, DiscGenics Inc., a US-based biopharmaceutical company, received FDA regenerative medicine advanced therapy designation for its injectable disc cell therapy (IDCT), which targets symptomatic lumbar degenerative disc disease. This cutting-edge therapy employs a live progenitor cell population derived from donated adult human intervertebral disc tissue. IDCT aims to boost disc volume, alleviate low back pain, and lessen the need for pain medication in affected patients.

In January 2023, Companion Spine LLC, a US-based spine care company, acquired Backbone SAS for an undisclosed amount. This acquisition is intended to enhance Companion's portfolio of medical implants for treating spine and back pain. Backbone SAS, based in France, specializes in developing and manufacturing medical devices for spine and back pain treatment.

Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health

North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the degenerative disc disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The degenerative disc disease treatment market consists of revenues earned by entities by providing services such as medical consultations, surgical procedures, and post-treatment rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The degenerative disc disease treatment market also includes sales of spinal implants, orthopedic braces, pain relief medications, physical therapy equipment, and diagnostic imaging tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Degenerative Disc Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on degenerative disc disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for degenerative disc disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The degenerative disc disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Conventional Drugs; Novel Therapies
  • 2) By Route Of Administration: Oral; Injectable
  • 3) By End User: Hospitals; Ambulatory Surgical Centers; Orthopedic Center
  • Subsegments:
  • 1) By Conventional Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Opioids; Muscle Relaxants; Corticosteroids; Antidepressants
  • 2) By Novel Therapies: Gene Therapy; Stem Cell Therapy; Platelet-Rich Plasma (PRP) Therapy; Biologic Agents; Regenerative Medicine; Cell-Based Therapies; Growth Factor Therapies
  • Companies Mentioned: Pfizer Inc.; Johnson And Johnson; Sanofi S.A.; AstraZeneca Plc; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r29955

Table of Contents

1. Executive Summary

2. Degenerative Disc Disease Treatment Market Characteristics

3. Degenerative Disc Disease Treatment Market Trends And Strategies

4. Degenerative Disc Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Degenerative Disc Disease Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Degenerative Disc Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Degenerative Disc Disease Treatment Market Growth Rate Analysis
  • 5.4. Global Degenerative Disc Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Degenerative Disc Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Degenerative Disc Disease Treatment Total Addressable Market (TAM)

6. Degenerative Disc Disease Treatment Market Segmentation

  • 6.1. Global Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Drugs
  • Novel Therapies
  • 6.2. Global Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectable
  • 6.3. Global Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Center
  • 6.4. Global Degenerative Disc Disease Treatment Market, Sub-Segmentation Of Conventional Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Opioids
  • Muscle Relaxants
  • Corticosteroids
  • Antidepressants
  • 6.5. Global Degenerative Disc Disease Treatment Market, Sub-Segmentation Of Novel Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gene Therapy
  • Stem Cell Therapy
  • Platelet-Rich Plasma (PRP) Therapy
  • Biologic Agents
  • Regenerative Medicine
  • Cell-Based Therapies
  • Growth Factor Therapies

7. Degenerative Disc Disease Treatment Market Regional And Country Analysis

  • 7.1. Global Degenerative Disc Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Degenerative Disc Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Degenerative Disc Disease Treatment Market

  • 8.1. Asia-Pacific Degenerative Disc Disease Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Degenerative Disc Disease Treatment Market

  • 9.1. China Degenerative Disc Disease Treatment Market Overview
  • 9.2. China Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Degenerative Disc Disease Treatment Market

  • 10.1. India Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Degenerative Disc Disease Treatment Market

  • 11.1. Japan Degenerative Disc Disease Treatment Market Overview
  • 11.2. Japan Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Degenerative Disc Disease Treatment Market

  • 12.1. Australia Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Degenerative Disc Disease Treatment Market

  • 13.1. Indonesia Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Degenerative Disc Disease Treatment Market

  • 14.1. South Korea Degenerative Disc Disease Treatment Market Overview
  • 14.2. South Korea Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Degenerative Disc Disease Treatment Market

  • 15.1. Western Europe Degenerative Disc Disease Treatment Market Overview
  • 15.2. Western Europe Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Degenerative Disc Disease Treatment Market

  • 16.1. UK Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Degenerative Disc Disease Treatment Market

  • 17.1. Germany Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Degenerative Disc Disease Treatment Market

  • 18.1. France Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Degenerative Disc Disease Treatment Market

  • 19.1. Italy Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Degenerative Disc Disease Treatment Market

  • 20.1. Spain Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Degenerative Disc Disease Treatment Market

  • 21.1. Eastern Europe Degenerative Disc Disease Treatment Market Overview
  • 21.2. Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Degenerative Disc Disease Treatment Market

  • 22.1. Russia Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Degenerative Disc Disease Treatment Market

  • 23.1. North America Degenerative Disc Disease Treatment Market Overview
  • 23.2. North America Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Degenerative Disc Disease Treatment Market

  • 24.1. USA Degenerative Disc Disease Treatment Market Overview
  • 24.2. USA Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Degenerative Disc Disease Treatment Market

  • 25.1. Canada Degenerative Disc Disease Treatment Market Overview
  • 25.2. Canada Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Degenerative Disc Disease Treatment Market

  • 26.1. South America Degenerative Disc Disease Treatment Market Overview
  • 26.2. South America Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Degenerative Disc Disease Treatment Market

  • 27.1. Brazil Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Degenerative Disc Disease Treatment Market

  • 28.1. Middle East Degenerative Disc Disease Treatment Market Overview
  • 28.2. Middle East Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Degenerative Disc Disease Treatment Market

  • 29.1. Africa Degenerative Disc Disease Treatment Market Overview
  • 29.2. Africa Degenerative Disc Disease Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Degenerative Disc Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Degenerative Disc Disease Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Degenerative Disc Disease Treatment Market Competitive Landscape
  • 30.2. Degenerative Disc Disease Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Degenerative Disc Disease Treatment Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline PLC
  • 31.2. Medtronic plc
  • 31.3. Amgen Inc.
  • 31.4. Baxter International Inc.
  • 31.5. B. Braun SE
  • 31.6. Zimmer Biomet Holdings Inc.
  • 31.7. Arthrex Inc.
  • 31.8. Ferring B.V.
  • 31.9. Biocon Limited
  • 31.10. Integra LifeSciences Holdings Corporation
  • 31.11. NuVasive Inc.
  • 31.12. Globus Medical Inc.
  • 31.13. Orthofix Medical Inc.
  • 31.14. RTI Surgical Holdings Inc.
  • 31.15. LifeNet Health

32. Global Degenerative Disc Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Degenerative Disc Disease Treatment Market

34. Recent Developments In The Degenerative Disc Disease Treatment Market

35. Degenerative Disc Disease Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Degenerative Disc Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Degenerative Disc Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Degenerative Disc Disease Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!